Teva Pharmaceutical Industries Limited (TEVA) Earnings
|
Expand Research on TEVA
| Next EPS Date | 5/8/24 | EPS Growth Rate | +30.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +2.1% | Revenue Growth Rate | +0.8% |
| Average % Move 1-Wk after EPS | +2.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/13/17 |  |
Q416 | $1.38 | $1.36 | +$0.02 | $6.25B | $6.26B | = |  | | Details |
| 8/3/17 | |
Q217 | $1.02 | $1.12 | -$0.10 | $5.7B | $5.76B | = | | | Details |
2/15/12  |
|
Q411 | $1.59 | $1.58 | +$0.01 | $5.68B | $5.61B | = | | | Details |
| 11/2/17 | |
Q317 | $1.00 | $1.04 | -$0.04 | $5.61B | $5.62B | = | | | Details |
| 5/11/17 | |
Q117 | $1.06 | $1.06 | $0.00 | $5.6B | $5.7B | = | | | Details |
| 11/15/16 |
|
Q316 | $1.31 | $1.29 | +$0.02 | $5.56B | $5.75B | = | | | Details |
| 2/8/18 | |
Q417 | $0.93 | $0.76 | +$0.17 | $5.5B | $5.31B |  |
| | Details |
| 2/6/14 |
|
Q413 | $1.42 | $1.40 | +$0.02 | $5.4B | $5.19B | |
| | Details |
